ADIL Company Profile and Key Details
Adial Pharmaceuticals, Inc.
ADIL Stock Price Chart
Stock Price Today
Adial Pharmaceuticals, Inc. (ADIL) stock declined over -3.38%, trading at $0.83 on NASDAQ, down from the previous close of $0.86. The stock opened at $0.86, fluctuating between $0.80 and $0.87 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.
Company Information
| Employees | 4 |
| Beta | 1.3 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) stock price is $0.83 in the last trading session. During the trading session, ADIL stock reached the peak price of $0.87 while $0.80 was the lowest point it dropped to. The percentage change in ADIL stock occurred in the recent session was -3.38% while the dollar amount for the price change in ADIL stock was -$0.03.
The NASDAQ listed ADIL is part of Biotechnology industry that operates in the broader Healthcare sector. Adial Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Catherine Fratila
Controller
Mr. John R. Martin J.D.
Gen. Counsel
Mr. Alex Lugovoy
Chief Bus. Officer
Dr. Jack W. Reich Ph.D.
Head of Regulatory
Mr. Mark H. Peikin
Chief Strategy Officer & Chief Devel. Officer
Mr. Cary John Claiborne MBA
Chief Executive Officer, Pres & Director
Mr. Joseph A. M. Truluck M.B.A., MBA
Chief Financial Officer, Treasurer & Sec.
Dr. Bankole A. Johnson DSc, FRCPsych, M.D., M.Phil, Ph.D.
Founder & Chief Medical Officer
ADIL's closing price is 15.28% higher than its 52-week low of $0.72 where as its distance from 52-week high of $4.17 is -80.1%.
Number of ADIL employees currently stands at 4.
Official Website of ADIL is: https://www.adialpharma.com
ADIL could be contacted at phone 434 422 9800 and can also be accessed through its website. ADIL operates from 1180 Seminole Trail, Charlottesville, VA 22901, United States.
ADIL stock volume for the day was 127.72K shares. The average number of ADIL shares traded daily for last 3 months was 182.49K.
The market value of ADIL currently stands at $5.37M with its latest stock price at $0.83 and 6.47M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com